Species Difference in the Metabolism of Mulberrin in Vitro and Its Inhibitory Effect on Cytochrome P450 and UDP-Glucuronosyltransferase Enzymes

被引:1
|
作者
Hu, Jiayin [1 ]
Hu, Tingting [1 ]
Guo, Zhe [1 ]
Song, Yonggui [2 ]
Shan, Lina [1 ]
Shi, Xianbao [1 ]
机构
[1] Jinzhou Med Univ, Affiliated Hosp 1, Jinzhou 121001, Peoples R China
[2] Jiangxi Univ Tradit Chinese Med, 1688 Meiling Rd, Nanchang 330006, Peoples R China
关键词
CYP; uridine 5'-diphosphate (UDP)-glucuronosyltransferase; liver microsome; interspecies dif-ference; mulberrin; Western blot analysis; DRUG-DRUG INTERACTIONS; HUMAN LIVER-MICROSOMES; HEPATIC-CLEARANCE; CANCER; GLUCURONIDATION; CYP3A4; UGT; IDENTIFICATION; CONSTITUENTS; PREVALENCE;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This study aimed to evaluate the interspecies difference in metabolism of mulberrin and examine the interaction between mulberrin and CYP enzymes or recombinant human uridine 5'-diphosphate (UDP)minipig (PLMs), monkey (MLMs), rabbit (RLMs), rat (RAMs), and mouse (MIMs) were used to investigate metabolic diversity among different species. Additionally, recombinant human supersomes were used to confirm that metabolic enzymes are involved in the biotransformation of mulberrin. We also evaluated the influence of mulberrin on protein expression by Western blot analysis. Mulberrin metabolism showed significant interspecies differences. We found four and two metabolites in phase I and II reaction systems, respectively. In phase I metabolism profiles of mulberrin for HLMs, PLMs and MLMs conformed to the classic Michaelis-Menten kinetics, RAMs and MIMs followed biphasic kinetics; phase II reaction of mulberrin in HLMs, DLMs, PLMs, MLMs, RLMs, RAMs and MIMs followed biphasic kinetics. UGT1A1 were the major CYP isoforms responsible for the metabolism of mulberrin. Mulberrin showed potent inhibitory effects against CYP3A4, CYP2C9, CYP2E1, UGT1A1, UGT1A3 and UGT2B7 with IC50 values of 54.21, 9.93, 39.12, 3.84, 2.01, 16.36 mu M, respectively. According to Western blot analysis, mulberrin can upregulate the protein expression of CYP2C19, and downregulate the expression levels of CYP3A5 and CYP2C9 in HepG2 cells as concentration increased. The interspecies comparisons can help find other species with metabolic pathways similar to those in humans for future in vivo studies.
引用
收藏
页码:669 / 678
页数:10
相关论文
共 50 条
  • [31] Overexpression of UDP-glucuronosyltransferase and cytochrome P450 enzymes confers resistance to sulfoxaflor in field populations of the aphid, Myzus persicae
    Pym, Adam
    Umina, Paul A.
    Reidy-Crofts, Jenny
    Troczka, Bartlomiej J.
    Matthews, Andrew
    Gardner, James
    Hunt, Benjamin J.
    van Rooyen, Anthony R.
    Edwards, Owain R.
    Bass, Chris
    INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2022, 143
  • [32] In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes
    Kong, Tae Yeon
    Kwon, Soon-Sang
    Cheong, Jae Chul
    Kim, Hee Seung
    Kim, Jin Young
    Lee, Hye Suk
    MOLECULES, 2018, 23 (04):
  • [33] In vitro metabolism of helenalin and its inhibitory effect on human cytochrome P450 activity
    Sadibolova, Michaela
    Juvonen, Risto O.
    Auriola, Seppo
    Bousova, Iva
    ARCHIVES OF TOXICOLOGY, 2022, 96 (03) : 793 - 808
  • [34] In vitro metabolism of helenalin and its inhibitory effect on human cytochrome P450 activity
    Michaela Šadibolová
    Risto O. Juvonen
    Seppo Auriola
    Iva Boušová
    Archives of Toxicology, 2022, 96 : 793 - 808
  • [35] Effect of dietary eugenol on xenobiotic metabolism and mediation of UDP-glucuronosyltransferase and cytochrome P450 1A1 expression in rat liver
    Iwano, Hidetomo
    Ujita, Wakako
    Nishikawa, Miyu
    Ishii, Satomi
    Inoue, Hiroki
    Yokota, Hiroshi
    INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2014, 65 (02) : 241 - 244
  • [36] Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins
    Barnes, Kyra J.
    Rowland, Andrew
    Polasek, Thomas M.
    Miners, John O.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (09) : 1097 - 1106
  • [37] Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins
    Kyra J. Barnes
    Andrew Rowland
    Thomas M. Polasek
    John O. Miners
    European Journal of Clinical Pharmacology, 2014, 70 : 1097 - 1106
  • [38] Inhibitory potential of yohimbine on cytochrome P450 enzymes in vitro
    Vay, M.
    Weiss, J.
    Skopp, G.
    Mikus, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S73 - S73
  • [39] Effect of cigarette smoke on UDP-glucuronosyltransferase activity and cytochrome P450 content in liver, lung and kidney microsomes in mice
    Villard, PH
    Herber, R
    Seree, EM
    Attolini, L
    Magdalou, J
    Lacarelle, B
    PHARMACOLOGY & TOXICOLOGY, 1998, 82 (02): : 74 - 79
  • [40] Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects
    Miyauchi, Eisuke
    Tachikawa, Masanori
    Decleves, Xavier
    Uchida, Yasuo
    Bouillot, Jean-Luc
    Poitou, Christine
    Oppert, Jean-Michel
    Mouly, Stephane
    Bergmann, Jean-Francois
    Terasaki, Tetsuya
    Scherrmann, Jean-Michel
    Lloret-Linares, Celia
    MOLECULAR PHARMACEUTICS, 2016, 13 (08) : 2631 - 2640